Agent says Lincecum not pursuing multi-year deal

Leave a comment

While speculation swirls about what kind of salary Tim Lincecum could command via arbitration later this offseason, agent Rick Thurman said yesterday that “as of today” the two-time Cy Young winner plans to “pursue a one-year deal” rather than sign a multi-year contract with the Giants.
John Shea of the San Francisco Chronicle reports that “the preference in Lincecum’s camp is to take full advantage of the arbitration system, which in turn would appease the players’ union” that “wants to see the process played out, if only so Lincecum could set a new bar for arbitration-eligible players.”
Serving as a guinea pig by going through the arbitration process would likely maximize Lincecum’s short-term earning potential while making the MLBPA happy, but by doing so he’d also risk giving up significant money in case of a serious injury. In other words the Giants would happily guarantee him at least $50 million and likely a whole lot more to buy out his arbitration eligibility and perhaps one year of free agency, whereas even a healthy, dominant Lincecum may not surpass that amount in total earnings via arbitration until his third hearing.
It’s hard to put myself in the shoes of a 25-year-old who’s just been named the league’s best pitcher in back-to-back seasons, but given the number of great young arms that have been ruined by injuries it might make sense to take slightly less money up front. Is the difference between making, say, $75 million or $60 million over the next three seasons worth the risk of a blown-out elbow or torn shoulder stopping Lincecum well short of either figure? Going year-to-year is maximum reward and maximum risk.

Drew Pomeranz: “I definitely feel like I can maybe help (as a reliever in the playoffs).”

SAN DIEGO, CALIFORNIA - SEPTEMBER 5:  Drew Pomeranz #31 of the Boston Red Sox pitches during the second inning of a baseball game against the San Diego Padres at PETCO Park on September 5, 2016 in San Diego, California.  (Photo by Denis Poroy/Getty Images)
Denis Poroy/Getty Images
1 Comment

Red Sox starter Drew Pomeranz hasn’t pitched in a week due to soreness in his left forearm. He threw a bullpen on Thursday afternoon and said, “I definitely feel like I can maybe help (as a reliever in the playoffs,” as ESPN’s Scott Lauber reports.

The Red Sox clinched the AL East on Wednesday, so they don’t need to rush Pomeranz along. And using him out of the bullpen might ultimately be best as he regressed quite a bit after coming to Boston from San Diego in July. In 13 starts with the Red Sox, Pomeranz has a 4.68 ERA with a 69/24 K/BB ratio in 67 1/3 innings.

Eduardo Rodriguez and Clay Buchholz have been throwing the ball quite well as of late. Paired with Rick Porcello and David Price, the Red Sox still have the depth to be menacing in the postseason.

Jesus Montero suspended 50 games for use of a stimulant

Seattle Mariners' Jesus Montero follows through on an RBI-double in the first inning of a spring training baseball game against the Kansas City Royals, Saturday, March 19, 2016, in Surprise, Ariz. (John Sleezer/The Kansas City Star via AP) MANDATORY CREDIT
4 Comments

Remember Jesus Montero? The former Yankees and Mariners prospect? Well, he was picked up by the Blue Jays back in March after the Mariners waived him and played 126 games for Triple-A Buffalo this year. That went alright, I suppose, with Montero hitting .317/.349/.438 with 11 homers. He played a bit of first base too, trying to break the mold he’s been stuck in as a 26-year-old DH.

If this season was a platform for him to make one last push to the bigs, the platform was just pulled out from under him: he has been suspended for 50 games after testing positive for dimethylbutylamine (DMBA), a stimulant in violation of the Minor League Drug Prevention and Treatment Program.

The minor league season is over, of course, so he’ll serve that suspension next season. Assuming the Jays keep him in the fold.